Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease
Alcmène Chalazonitis, Meenakshi Rao, David Sulzer
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota
Qingxia Gan, Maoyao Peng, Haobo Wei, et al.
Food & Function (2024) Vol. 15, Iss. 6, pp. 2920-2938
Closed Access | Times Cited: 18
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
The Aging Enteric Nervous System
Tinh Thi Nguyen, Peter Baumann, Oliver Tüscher, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9471-9471
Open Access | Times Cited: 18
The Molecular Gut-Brain Axis in Early Brain Development
Fahim Muhammad, Bufang Fan, Ruoxi Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15389-15389
Open Access | Times Cited: 24
Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111349-111349
Open Access
CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease
Emmi Pakarinen, Päivi Lindholm
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
Yee Jie Yeap, Tng J. W. Teddy, Mok Jung Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2523-2523
Open Access | Times Cited: 9
Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson’s disease
Jéssica Grigoletto, Fabiana Miraglia, Laura Benvenuti, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Developmental origins of Parkinson disease: Improving the rodent models
Irene Jiménez-Salvador, Patricia Meade, Eldris Iglesias, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101880-101880
Open Access | Times Cited: 8
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease From Mice to Human
Martina Montanari, Paola Imbriani, Paola Bonsi, et al.
(2023)
Open Access | Times Cited: 8
Pesticides and the Gut Microbiota: Implications for Parkinson’s Disease
Nabanita Ghosh, Krishnendu Sinha, Parames C. Sil
Chemical Research in Toxicology (2024) Vol. 37, Iss. 7, pp. 1071-1085
Closed Access | Times Cited: 2
The mycobiota-gut-brain axis in Parkinson's disease: A review on what we know and what paths we can still take to advance this field of study
Dionísio Pedro Amorim Neto, Anderson S. Sant’Ana
Fungal Biology Reviews (2023) Vol. 46, pp. 100327-100327
Open Access | Times Cited: 4
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells
Giada Botti, Barbara Pavan, Anna Bianchi, et al.
Journal of Functional Foods (2024) Vol. 119, pp. 106331-106331
Open Access | Times Cited: 1
Microbiome-based therapies for Parkinson’s disease
Mudassir Alam, Kashif Abbas, Mohd Rais Mustafa, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Salsolinol Protects SH-SY5Y Cells Against MPP+ Damage and Increases Enteric S100-Immunoreactivity in Wistar Rats
Magdalena Kurnik‐Łucka, Gniewomir Latacz, Joanna Goryl, et al.
Neurochemical Research (2022)
Open Access | Times Cited: 6
The Golgi complex of dopaminergic enteric neurons is fragmented in a hemiparkinsonian rat model
Mireia Cara‐Esteban, Maria Pilar Marín, Emma Martínez‐Alonso, et al.
Microscopy Research and Technique (2023) Vol. 87, Iss. 2, pp. 373-386
Open Access | Times Cited: 2
Alpha-synuclein distribution and seeding activity in rectal biopsies in Parkinson’s disease
Annika Kluge, Carmen Kintrup, Kristína Kulcsarová, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Characterizing enteric neurons in dopamine transporter (DAT)‐Cre reporter mice reveals dopaminergic subtypes with dual‐transmitter content
Sherilyn Junelle Recinto, Shobina Premachandran, Sriparna Mukherjee, et al.
European Journal of Neuroscience (2024) Vol. 59, Iss. 10, pp. 2465-2482
Open Access
Characterizing enteric neurons in Dopamine Transporter (DAT)-Cre reporter mice reveals dopaminergic subtypes with dual-transmitter content
Sherilyn Junelle Recinto, Shobina Premachandran, iparna Mukherjee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top